Bharat Baral

Bharat Baral currently serves as CMC Manager at Geron Corporation, providing technical leadership for oligonucleotide drug substance and drug product development since January 2021. Prior experience includes a role as Scientist at Janssen BioPharma from July 2015 to January 2021, focusing on HBV drug discovery and the development of targeted delivery methods for oligonucleotide-based drugs. Bharat also worked as a Business Analyst at Optum, where responsibilities involved analyzing business processes and managing databases for various benefit groups, and held positions as a Quality Control Analyst at Janssen Pharmaceuticals, Development Associate at Geron Corporation, and Research Associate II at Agraquest Inc, where extensive organic-analytical chemistry work was conducted. Bharat Baral earned a Master of Science in Chemistry from the University of Idaho in 2010.